Sotabase

Career

· Graduate Student, Interactive Robotics Group

Publications (19)

Non‐myeloablative human leukocyte antigen‐matched related donor transplantation in sickle cell disease: outcomes from three independent centres
British Journal of Haematology · 2021
52
cited
Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings
European Respiratory Journal · 2013
46
cited
Extended treatment response to imatinib in Rosai‐Dorfman disease
European Journal of Haematology · 2021
6
cited
Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center
2020
2
cited
Complications in Pregnancy of Sickle Cell Disease
2020
1
cited
Effect of KRAS and P-STAT3 inhibition by SBT-100 on gemcitabine and pancreatic cancer growth in vivo.
2017
1
cited
Understanding the privacy rights of the African child in the digital era
African Human Rights Law Journal · 2021
1
cited
Abstract 1544: Cell penetrating single domain antibody (sdAb) SBT-100 binds KRAS and inhibits growth of human cancers with KRAS activating mutations
Immunology · 2019
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
2017
Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells
Molecular and Cellular Biology / Genetics · 2018
Abstract P6-12-13: Single domain antibody (SBT-100) inhibits growth of human HER2+ and triple negative breast cancers (TNBC) in xenografts by binding STAT3 and P-STAT3
2017
a clinical ausit of selected predictors of mortality of patients admitted to Charlotte Maxeke Johannesburg academic hospital intensive care unit with human immunodeficiency virus and tuberculosis co-infection
2019
A novel single domain antibody (sdAb) SBT-100 targeting intracellular STAT3 to inhibit major subtypes of human breast cancer.
2016
A novel single domain antibody (sdAb) SBT-100 to target intracellular STAT3 to affect growth and regression of human triple negative breast cancer (TNBC) cells.
2016
Digital papillary adenocarcinoma of the ankle
2017
MICROFINANCE: A STUDY ON THE POVERTY ALLEVIATION TOOL IN RURAL INDIA
2020
Refractory acquired angioedema in chronic lymphocytic leukemia
Leukemia and Lymphoma · 2020
Safety monitoring practice during the initiation of tyrosine kinase inhibitors (TKIs) for NSCLC treatment.
Journal of Clinical Oncology · 2022
Single domain antibody (SBT-100) crosses the blood brain barrier (BBB) and inhibits human glioblastoma by selectively targeting KRAS and P-STAT3.
2017
Sotabase